Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Samrat Pharmachem has informed BSE that its Board of Directors will meet on Saturday, May 30, 2026, at 2:00 PM at the corporate office in Andheri (West), Mumbai. The key agenda item is to consider, approve and take on record the Audited Standalone Financial Results under Ind-AS for the financial year ended March 31, 2026, along with the statutory auditor's report. The notice is filed under SEBI LODR Regulation 29. The company will intimate the results to the exchanges after the meeting and publish them on its website and in the press.
No direct impact on shareholders or stock price; this is a routine regulatory advance notice ahead of the FY26 annual results announcement, which is expected on or after May 30, 2026.